Received Jun 26, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | Y012865 | — |
Confirmed no symptomatic adverse events reported; Caller states that a vaccine was activated by attaching a syringe on 6-JUN-2025 but ended up not being used and was immediately placed back in the fridge. The dose was then administered to a patient on 9-JUN-2025.; This spontaneous report was received from a medical assistant on 13-Jun-2025, referring to a 37-year-old female patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 09-Jun-2025, the patient was vaccinated with human papillomavirus 9-valent vaccine, recombinant (GARDASIL 9), lot #Y012865, expiration date: 10-Oct-2026, 0.5 mL / once, for prophylaxis (dose form, route of administration and anatomical site were not provided). The reporter stated that a vaccine was activated by attaching a syringe on 6-JUN-2025 but ended up not being used and was immediately placed back in the fridge. The dose was then administered to the patient on 09-JUN-2025 (Product storage error). No symptomatic adverse events reported.